Rodberg James sold $37K of SGHT
Rodberg James (Chief Financial Officer) sold 6,902 shares of Sight Sciences, Inc. (SGHT) at $5.36 on 2026-07-02 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
Because the sale is explicitly under a pre-arranged 10b5-1 plan and is relatively small in dollar terms, it is more likely to be informational for monitoring than a catalyst.
Market read
Traders may log the sale for insider-flow tracking, but it does not provide new operational or financial guidance.
What to watch
The disclosure doesn’t indicate whether other insiders sold/bought around the same time, nor does it quantify total insider activity beyond this single transaction.
Background
The article is a primary-source SEC Form 4 insider transaction for Sight Sciences, Inc., reported by the CFO.
Ticker impact
Sight Sciences CFO Rodberg James sold 6,902 shares for about $37.0K under a pre-arranged 10b5-1 plan, per Form 4.
Low likelihood of a sustained price move; any reaction is likely muted and short-lived.
The filing is a Form 4 insider transaction with a small dollar value relative to typical market moves and explicitly states a pre-arranged 10b5-1 plan.
Market effects
No clear sector read-through; this is company-specific insider transaction data.
None indicated.
None indicated.
Counterpoint
Even with a 10b5-1 plan, repeated insider selling can still be interpreted by some traders as confidence erosion, especially in thinly traded names.
Key entities
- issuerSight Sciences, Inc.
Subject of the Form 4 insider transaction; CFO sold shares under a 10b5-1 plan.
- insiderRodberg James
Chief Financial Officer who executed the open-market sale.
